1. Home
  2. KYMR vs ESE Comparison

KYMR vs ESE Comparison

Compare KYMR & ESE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KYMR
  • ESE
  • Stock Information
  • Founded
  • KYMR 2015
  • ESE 1990
  • Country
  • KYMR United States
  • ESE United States
  • Employees
  • KYMR N/A
  • ESE N/A
  • Industry
  • KYMR Medicinal Chemicals and Botanical Products
  • ESE Telecommunications Equipment
  • Sector
  • KYMR Health Care
  • ESE Telecommunications
  • Exchange
  • KYMR Nasdaq
  • ESE Nasdaq
  • Market Cap
  • KYMR 4.7B
  • ESE 5.5B
  • IPO Year
  • KYMR 2020
  • ESE N/A
  • Fundamental
  • Price
  • KYMR $67.94
  • ESE $215.89
  • Analyst Decision
  • KYMR Strong Buy
  • ESE Strong Buy
  • Analyst Count
  • KYMR 19
  • ESE 2
  • Target Price
  • KYMR $69.58
  • ESE $237.50
  • AVG Volume (30 Days)
  • KYMR 722.7K
  • ESE 199.1K
  • Earning Date
  • KYMR 11-04-2025
  • ESE 11-20-2025
  • Dividend Yield
  • KYMR N/A
  • ESE 0.15%
  • EPS Growth
  • KYMR N/A
  • ESE 193.11
  • EPS
  • KYMR N/A
  • ESE 11.55
  • Revenue
  • KYMR $43,735,000.00
  • ESE $1,095,388,000.00
  • Revenue This Year
  • KYMR $60.88
  • ESE $17.58
  • Revenue Next Year
  • KYMR N/A
  • ESE $6.83
  • P/E Ratio
  • KYMR N/A
  • ESE $18.94
  • Revenue Growth
  • KYMR N/A
  • ESE 6.68
  • 52 Week Low
  • KYMR $19.45
  • ESE $127.17
  • 52 Week High
  • KYMR $68.80
  • ESE $229.46
  • Technical
  • Relative Strength Index (RSI)
  • KYMR 68.81
  • ESE 48.37
  • Support Level
  • KYMR $63.86
  • ESE $211.27
  • Resistance Level
  • KYMR $68.80
  • ESE $227.46
  • Average True Range (ATR)
  • KYMR 3.52
  • ESE 9.90
  • MACD
  • KYMR 0.19
  • ESE -0.45
  • Stochastic Oscillator
  • KYMR 94.07
  • ESE 44.83

About KYMR Kymera Therapeutics Inc.

Kymera Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to reinventing the treatment of human disease through the development of, differentiated medicines that address health problems and that meaningfully improve patients' lives. It is committed to novel technologies to address targets that have known disease-causing biology, but which have not been drugged, or have been inadequately drugged, often based on limitations of existing technologies. Its approach is intended to discover and develop a new generation of medicines in a disease-agnostic manner. Its product pipelines are STAT6, TYK2, and IRAK4.

About ESE ESCO Technologies Inc.

ESCO Technologies Inc sells engineered products and systems for utility, industrial, aerospace, and commercial applications. The firm operates in three segments: Aerospace and Defense, Utility Solutions Group (USG), and Test. The Aerospace and Defense segment designs and manufactures specialty filtration and naval products. The USG segment provides diagnostic testing solutions. The Test segment provides its customers with the ability to identify, measure, and contain magnetic, electromagnetic, and acoustic energy.

Share on Social Networks: